Skip to main content
SpringerLink
Log in

Controlling Cervical Cancer

  • Editorial
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bosch FX, Burchell AN, Schiffman M, et al. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 2008; 26 Suppl. 10: K1–16

    Article  Google Scholar 

  2. Kim JJ, Brisson M, Edmunds WJ, et al. Modeling cervical cancer prevention in developed countries. Vaccine 2008; 26 Suppl. 10: K76–86

    Article  Google Scholar 

  3. McCrory DC, Matchar DB, Bastian L, et al. Evaluation of cervical cytology. Evid Rep Technol Assess (Summ) 1999; 5: 1–64.

    Google Scholar 

  4. Wright TC, Bosch FX, Franco EL, et al. Chapter 30: HPV vaccines and screening in the prevention of cervical cancer. Conclusions from a 2006 workshop of international experts. Vaccine 2006; 24 Suppl. 3: S251–61

    Article  Google Scholar 

  5. zur Hausen H, Meinhof W, Scheiber W, et al. Attempts to detect virus-specific DNA in human tumors: I. Nucleic acid hybridizations with complementary RNA of human wart virus. Int J Cancer 1974; 13 (5): 650–6

    Article  PubMed  CAS  Google Scholar 

  6. Parkin DM, Bray F. Chapter 2: the burden of HPV-related cancers. Vaccine 2006; 24 Suppl. 3; S3/11–25

    Google Scholar 

  7. Koshiol J, Lindsay L, Pimenta JM, et al. Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol 2008; 168: 123–37

    Article  PubMed  Google Scholar 

  8. Datta SD, Koutsky LA, Ratelle S, et al. Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003–2005. Ann Intern Med 2008; 148: 493–500

    PubMed  Google Scholar 

  9. Techakehakij W, Feldman RD. Cost-effectiveness of HPV vaccination compared with Pap smear screening on a national scale: a literature review. Vaccine 2008; 26 (49): 6258–65

    Article  PubMed  Google Scholar 

  10. Stanley M, Gissmann L, Nardelli-Haefliger D. Immunobiology of human papillomavirus infection and vaccination: implications for second generation vaccines. Vaccine 2008; 26 Suppl. 10: K62–7

    Article  Google Scholar 

  11. Gravitt PE, Coutlée F, Iftner T, et al. New technologies in cervical cancer screening. Vaccine 2008; 26 Suppl. 10: K42–52

    Article  Google Scholar 

  12. Cuzick J, Arbyn M, Sankaranarayanan T, et al. Overview of human papilloma virus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine 2008; 26 Suppl. 10: K29–41

    Article  Google Scholar 

  13. Kitchener HC, Castle PE, Cox JT. Achievements and limitation of cervical cytology screening. In: Bosch FX, editor. HPV vaccines and screening in the prevention of cervical cancer. Vaccine 2006; 24 Suppl. 3: S3–63

    Google Scholar 

  14. WHO. Comprehensive cervical cancer control: a guide to essential practice. Geneva: WHO, 2006 [online]. Available from URL: http://www.WHO.INT/reproductive-health/publications/cervical_cancer_gep/text.pdf [Accessed 2009 Feb 10]

  15. Kim JJ. Human papillomavirus vaccination in the UK. BMJ 2008; 337: a842

    Google Scholar 

  16. Haug CJ. Human papillomavirus vaccination: reasons for caution. N Engl J Med 2008; 359 (8): 861–2

    Article  PubMed  CAS  Google Scholar 

  17. Hughes JP, Garnett GP, Koutsky L. The theoretical population-level impact of a prophylactic human papilloma virus vaccine. Epidemiology 2002; 13: 631–9

    Article  PubMed  Google Scholar 

  18. Dasbach EJ, Elbasha EH, Insinga RP. Mathematical models for predicting the epidemiologic and economic impact of vaccination against human papillomavirus infection and disease. Epidemiol Rev 2006; 28: 88–100

    Article  PubMed  Google Scholar 

  19. Barnabas RV, Laukkanen P, Koskela P, et al. Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses. PLoS Med 2006; 3: e138

    Google Scholar 

  20. Elbasha EH, Dasbach EJ, Insinga RP. Model for assessing human papillomavirus vaccination strategies. Emerg Infect Dis 2007; 13: 28–41

    Article  PubMed  Google Scholar 

  21. Newall AT, Beutels P, Wood JG, et al. Cost-effectiveness analyses of human papillomavirus vaccination. Lancet Infect Dis 2007; 7: 289–96

    Article  PubMed  Google Scholar 

  22. Barnabas RV, Kulasingam SL. Economic evaluations of human papillomavirus vaccines. Expert Rev Pharmacoeconomics Outcomes Res 2007; 7: 1–17

    Article  Google Scholar 

  23. Marra F, Cloutier K, Oteng B, et al. Effectiveness and cost effectiveness of human papillomavirus vaccine: a systematic review. Pharmacoeconomics 2008; 27 (2): 127–47

    Article  Google Scholar 

  24. Reduction in the risk of cervical cancer by vaccination against human papillomavirus (HPV): a health technology assessment. Summary. Health Technol Assess 2007; 9 (1) [online]. Available from URL: http://www.sst.dk/publ/Publ2007/MTV/HPV/HPV_vaccination_smfatn_en.pdf [Accessed 2008 Nov 13]

  25. Jit M, Choi YH, Edmunds WJ. Economic evaluation of human papillomavirus vaccination in the United Kingdom. BMJ 2008; 337: a769

    Google Scholar 

  26. Kim JJ, Goldie SJ. Health and economic implications of HPV vaccination in the United States. N Engl J Med 2008; 359: 821–32

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory for Mother and Child Health, Department of Public Health, Milan, Italy

    Maurizio Bonati

  2. Institute for Pharmacological Research “Mario Negri”, Via G. La Masa 19, 20156, Milan, Italy

    Silvio Garattini

Authors
  1. Maurizio Bonati
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Silvio Garattini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Silvio Garattini.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bonati, M., Garattini, S. Controlling Cervical Cancer. Pharmacoeconomics 27, 91–93 (2009). https://doi.org/10.2165/00019053-200927020-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-200927020-00001

Search

Navigation